BioCentury | Sep 8, 2008
Clinical News

S: Pivotal trial started

...pivotal STROLL trial in about 250 patients. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Product: S.M.A.R.T. stent...
BioCentury | Jun 20, 2005
Clinical News

SMART Control Stent: Post-marketing study started

...JNJ subsidiary Cordis Corp. (Miami Lakes, Fla.) began the head-to-head German SUPER SL study comparing SMART Control...
...Hill, N.J.) markets Luminexx 6F vascular stent. Johnson & Johnson (JNJ), New Brunswick, N.J. Product: SMART Control...
Items per page:
1 - 2 of 2